
Browsing restrictions can be lifted for a fee.
-
Jackson acquisition company ii
0.71%
Avg of Sector
0.30%
S&P500
Jackson Acquisition Company II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search for a target business in the healthcare services and healthcare technology sector. The company was incorporated in 2024 and is based in Alpharetta, Georgia.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Jackson acquisition company ii (JACS-UN) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating JACS-UN's short-term business performance and financial health. For the latest updates on JACS-UN's earnings releases, visit this page regularly.
At the end of the period, Jackson acquisition company ii (JACS-UN) held Total Cash and Cash Equivalents of 721.66K, accounting for 0 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
The latest valuation data shows Jackson acquisition company ii (JACS-UN) has a Price-To-Earnings (PE) ratio of 33.44 and a Price/Earnings-To-Growth (PEG) ratio of 0.38. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.